KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Parker-Hannifin (PH) Cash & Equivalents (2016 - 2025)

Parker-Hannifin (PH) has disclosed Cash & Equivalents for 17 consecutive years, with $427.0 million as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents rose 7.96% to $427.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $427.0 million through Dec 2025, up 7.96% year-over-year, with the annual reading at $467.0 million for FY2025, 10.66% up from the prior year.
  • Cash & Equivalents for Q4 2025 was $427.0 million at Parker-Hannifin, down from $473.0 million in the prior quarter.
  • The five-year high for Cash & Equivalents was $756.1 million in Q4 2022, with the low at $371.1 million in Q3 2024.
  • Average Cash & Equivalents over 5 years is $481.2 million, with a median of $467.4 million recorded in 2022.
  • The sharpest move saw Cash & Equivalents skyrocketed 68.21% in 2022, then tumbled 49.37% in 2023.
  • Over 5 years, Cash & Equivalents stood at $449.5 million in 2021, then surged by 68.21% to $756.1 million in 2022, then crashed by 49.37% to $382.8 million in 2023, then grew by 3.32% to $395.5 million in 2024, then grew by 7.96% to $427.0 million in 2025.
  • According to Business Quant data, Cash & Equivalents over the past three periods came in at $427.0 million, $473.0 million, and $467.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.